Results 61 to 70 of about 29,043 (297)
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
Ortung verschuetteter Bergleute. Anforderungen und Pruefvorschriften fuer Ortungssysteme Schlussbericht [PDF]
This research project is concerned with the question of the properties, which a usable system for the location of persons buried alive should have, and of how to check these.
Fischer, D. +1 more
core
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto +12 more
wiley +1 more source
Scallop DMT functions as a Ca2+ transporter [PDF]
We identified a DMT (divalent metal transporter) homologous protein that functions as a Ca2+ transporter. Scallop DMT cDNA encodes a 539-amino-acid protein with 12 putative membrane-spanning domains and has a consensus transport motif in the fourth ...
Nakao, Kenji +6 more
core +1 more source
Complex Noise Analysis of DMT [PDF]
In this paper, we consider discrete multitone (DMT) or baseband orthogonal frequency-division multiplexing (OFDM) modulation and perform a detailed noise analysis which takes into account dependencies and power (variance) differences of real and imaginary part after the complex-valued discrete Fourier transform (DFT).
openaire +1 more source
“Low‐Positive” MOG‐IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis
ABSTRACT Objective To determine the prevalence and clinical characteristics of patients with “low‐positive” (LP) MOG‐IgG (titres 1:160–1:320) among adults with a first demyelinating event (FDE) suggestive of multiple sclerosis (MS). Methods From the Barcelona CIS inception cohort, we included adult patients with serum collected ≤ 6 months from the FDE.
Javier Villacieros‐Álvarez +29 more
wiley +1 more source
DMT alters cortical travelling waves [PDF]
Psychedelic drugs are potent modulators of conscious states and therefore powerful tools for investigating their neurobiology. N,N, Dimethyltryptamine (DMT) can rapidly induce an extremely immersive state of consciousness characterized by vivid and ...
Rufin VanRullen +11 more
core +1 more source
Background: The spectrum of disease-modifying therapies (DMTs) for people with multiple sclerosis (PwMS) has expanded over years, but data on treatment strategies is largely lacking. DMT switches are common clinical practice.
Niklas Frahm +14 more
doaj +1 more source
The diversity-multiplexing tradeoff (DMT) in a multiple-input multiple-output (MIMO) free-space optical (FSO) communication with limited channel state information at the transmitter (CSIT) is investigated.
Pranav Sharda, Manav R. Bhatnagar
doaj +1 more source
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine +40 more
wiley +1 more source

